Armata Pharmaceuticals Financial Overview
Armata Pharmaceuticals's market cap is currently $224.27M. The company's EPS TTM is $-0.74; its P/E ratio is -4.66; Armata Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
